´ëÇѽŰæÅðÇ༺Áúȯ ÇÐȸ ⸳(ÁغñÀ§¿øÀå: ¼¿ï´ëÀÇ´ë ½Å°æ°úÇבּ¸¼ÒÀå ¼À¯Çå±³¼ö)À» ±â³äÇÑ ±¹Á¦ ½ÉÆ÷Áö¾öÀÌ ¿À´Â 14ÀÏ ¿ÀÀü 9½ÃºÎÅÍ 6½Ã±îÁö ¿öÄ¿Èú È£ÅÚ, ¹«±ÃÈ È¦¿¡¼ ±¹³»¿Ü Ä¡¸Å, ÆÄŲ½¼º´, ·ç°Ô¸¯º´, ³ú ¿µ»óºÐ¾ß µîÀÇ ¼¼°èÀû ¼®ÇеéÀÌ °¡¿îµ¥ °³ÃֵȴÙ.
À̳¯ â¼³µÉ ±âÃÊÀÇÇÐ, »ý¸í°úÇÐ, ÀÓ»óÀÇÇÐÀÇ ¸ðµç Çй®ºÐ¾ß¸¦ ÅëÇÕÇÑ ´ëÇѽŰæÅðÇ༺Áúȯ ÇÐȸ´Â ±¹°¡°¡ “³ú¿¬±¸ÃËÁø¹ý”¿¡ ÀÇ°Å ³ú ¿¬±¸ ƯÈ÷ ³úÁúȯ ¿¬±¸¸¦ È°¼ºÈÇϱâ À§ÇØ ÃßÁøÇÏ´Â Á¦2´Ü°è(2008-2017) ³ú ¿¬±¸ ÃËÁø ½ÃÃ¥À» ¸¶·ÃÇϴµ¥ ÁßÃßÀû ¿ªÇÒÀ» ´ã´çÇÏ°Ô µÈ´Ù.
½Å°æÅðÇ༺ÁúȯÇÐȸ ⸳±â³ä ±¹Á¦½ÉÆ÷Áö¾ö
(4¿ù 14ÀÏ ¿ÀÀü 9½Ã ~ ¿ÀÈÄ 6½Ã, À§Ä¿ÈúÈ£ÅÚ 1Ãþ)
Date: April 14, 2007 (Sat) Place: Sheraton Walkerhill Hotel (Mugunghwa Ball Room 1st floor)
8:00 ~ 8:50 Registration
9:00 ~ 9:05 Opening remark (Yoo-Hun Suh, Chair of Organizing Committee)
9:05 ~ 9:10 Welcome remark (Hyung Gun Chung, Member of the National Assembly)
9:10 ~ 9:15 Welcome remark (Sang-Mok Lee, Derector General, Basic Res. Bureau)
Section 1. Pathogenesis of Neurodegenerative Disorders (¥°) Chair : Kwang-Woo Lee/ Sang Mee Ahn
9:15 ~ 9:55 Alzheimer's disease as proteolytic disorders (Saido, Japan)
9:55 ~ 10:25 New mediator of amyloid toxicity and memory impairment (Yong-Keun Jung, Korea)
10:25 ~ 11:05 Pathogenesis of ALS and its therapeutic implication (Mitsumoto Hiroshi, USA)
Section 2. Pathogenesis of Neurodegenerative Disorders (¥±) Chair : Beum-Saeng Kim/ In Kwa Jung
11:05 ~ 11:45 The mechanisms of Parkinson’s disease: insights obtained from inherited forms of Parkinson’s disease (Nobu Hattori, Japan)
11:45 ~ 12:15 Genetics of PD: SNU experience (Beom-Seok Jeon, Korea)
12:15 ~ 12:55 Ganglioside-induced Aβ assembly in Alzheimer disease (Katsuhiko Yanagisawa, Japan)
12:55 ~ 2:00 Lunch (provided) Lunch Seminar
1. Role of cholinergic and dopamine system in cognitive deficits of Lewy body disease (Chong Sik Lee)
2. GSK-3 as a neuroprotective target for neurodegenerative diseases (Seung Hyun Kim)
Section 3. Spectrum of Lewy Body Disease Chair : Zang-Hee Cho/ Sang Eun Kim
2:00 ~ 2:40 Lewy body disease including PD, PDD and DLB (Kenji Kosaka, Japan)
2:40 ~ 3:20 PET Imaging of Lewy body disease and Alzheimer disease (David Brooks, UK)
3:20 ~ 4:00 Multi-Tracer Imaging of the Cholinergic System: Preclinical and Clinical Studies (M. Kilbourn, USA)
4:00 ~ 4:30 [Break]
Section 4. Therapeutic Strategy for Neurodegenerative Disorders Chair : Byeong Kil Yeon/ Jae Woo Kim
4:30 ~ 5:00 Therapeutic strategy for AD (Yoo-Hun Suh, Korea)
5:00 ~ 5:30 Gene and cell therapy for neurodegenerative disorders (Seung U Kim, Korea)
5:30 ~ 6:00 Surgical treatment for movement disorders (Jin Woo Chang, Korea)
6:10 ~ 6:40 Inaugural Meeting of the Korean Society for Neurodegenerative Disorders